MedsFacts Reports covering ADELAVIN-NO.9
Directory listing ordered by most common adverse events for ADELAVIN-NO.9
Please choose an event type to view the corresponding MedsFacts report:
HEPATIC NEOPLASM MALIGNANT ( 6 FDA reports)
GRANULOCYTOPENIA ( 5 FDA reports)
STEVENS-JOHNSON SYNDROME ( 5 FDA reports)
ASCITES ( 4 FDA reports)
HEPATIC FUNCTION ABNORMAL ( 4 FDA reports)
HAEMATEMESIS ( 3 FDA reports)
HEPATIC ENCEPHALOPATHY ( 3 FDA reports)
PAIN ( 3 FDA reports)
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME ( 3 FDA reports)
BLOOD UREA INCREASED ( 2 FDA reports)
DEHYDRATION ( 2 FDA reports)
DEPRESSION ( 2 FDA reports)
GASTRIC ULCER ( 2 FDA reports)
GENERAL PHYSICAL HEALTH DETERIORATION ( 2 FDA reports)
HYPERTENSION ( 2 FDA reports)
LIVER DISORDER ( 2 FDA reports)
PYREXIA ( 2 FDA reports)
STOMATITIS ( 2 FDA reports)
DISEASE PROGRESSION ( 1 FDA reports)
MULTI-ORGAN FAILURE ( 1 FDA reports)
RENAL CELL CARCINOMA STAGE IV ( 1 FDA reports)
GRANULOCYTOPENIA ( 5 FDA reports)
STEVENS-JOHNSON SYNDROME ( 5 FDA reports)
ASCITES ( 4 FDA reports)
HEPATIC FUNCTION ABNORMAL ( 4 FDA reports)
HAEMATEMESIS ( 3 FDA reports)
HEPATIC ENCEPHALOPATHY ( 3 FDA reports)
PAIN ( 3 FDA reports)
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME ( 3 FDA reports)
BLOOD UREA INCREASED ( 2 FDA reports)
DEHYDRATION ( 2 FDA reports)
DEPRESSION ( 2 FDA reports)
GASTRIC ULCER ( 2 FDA reports)
GENERAL PHYSICAL HEALTH DETERIORATION ( 2 FDA reports)
HYPERTENSION ( 2 FDA reports)
LIVER DISORDER ( 2 FDA reports)
PYREXIA ( 2 FDA reports)
STOMATITIS ( 2 FDA reports)
DISEASE PROGRESSION ( 1 FDA reports)
MULTI-ORGAN FAILURE ( 1 FDA reports)
RENAL CELL CARCINOMA STAGE IV ( 1 FDA reports)